This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Inventor Jennifer Lynn Fulton: Pioneering Pharmaceutical Innovations
Introduction
Jennifer Lynn Fulton, based in Longmont, Colorado, is an accomplished inventor known for her significant contributions to the field of pharmaceuticals. She currently holds one patent that plays a pivotal role in the treatment of abnormal cell growth, including cancer. Her work is emblematic of the innovative spirit that drives advancements in medical science.
Latest Patents
Jennifer Lynn Fulton’s patent revolves around 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors. This invention relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, where certain groups are defined in the patent. It further covers pharmaceutical compositions comprising these compounds and salts, along with methods and applications for treating abnormal cell growth in individuals who require such interventions. Notably, her patent includes solid forms of the compound 8-((2-fluoro-4-(methylthio)phenyl)amino)-2-(2-hydroxyethoxy)-7-methyl-3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-dione.
Career Highlights
Jennifer has established herself as a key innovator at Pfizer Corporation, a leading player in the global pharmaceutical industry. Her work not only showcases her expertise in medicinal chemistry but also underscores her commitment to developing life-changing treatments for patients.
Collaborations
Throughout her career, Jennifer has collaborated with notable coworkers, including Shelley Allen and Patrick Michael Doerner Barbour. These partnerships highlight the importance of teamwork in the innovation process, as diverse expertise contributes to the advancement of groundbreaking pharmaceutical discoveries.
Conclusion
Jennifer Lynn Fulton exemplifies the essence of innovation within the pharmaceutical industry. Her patent related to MEK inhibitors demonstrates her dedication to addressing complex medical challenges. With her inventive spirit and collaboration with other talented professionals at Pfizer Corporation, Jennifer continues to pave the way for advancements that have the potential to benefit countless individuals in need of effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile